[go: up one dir, main page]

Chowdhury et al., 2008 - Google Patents

Exploring inhibitor binding at the S′ subsites of cathepsin L

Chowdhury et al., 2008

View PDF
Document ID
5225652127709142482
Author
Chowdhury S
Joseph L
Kumar S
Shenoy R
Bhat S
Ziomek E
Ménard R
Sivaraman J
Purisima E
Publication year
Publication venue
Journal of medicinal chemistry

External Links

Snippet

We report a series of noncovalent, reversible inhibitors of cathepsin L that have been designed to explore additional binding interactions with the S′ subsites. The design was based on our previously reported crystal structure that suggested the possibility of …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6427Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489Metalloendopeptidases (3.4.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases Endopeptidases (3.4.21-3.4.25) derived from bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes

Similar Documents

Publication Publication Date Title
Gál et al. A true autoactivating enzyme: structural insight into mannose-binding lectin-associated serine protease-2 activations
Zong et al. Crystal structures of Staphylococcus aureus sortase A and its substrate complex
Steinkühler et al. Product inhibition of the hepatitis C virus NS3 protease
Adams-Cioaba et al. Structural basis for the recognition and cleavage of histone H3 by cathepsin L
Cunningham et al. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia
Xue et al. Conformational change in rhomboid protease GlpG induced by inhibitor binding to its S′ subsites
Turner et al. Structural locations and functional roles of new subsites S5, S6, and S7 in memapsin 2 (β-secretase)
LaLonde et al. Use of Papain as a Model for the Structure-Based Design of Cathepsin K Inhibitors: Crystal Structures of Two Papain− Inhibitor Complexes Demonstrate Binding to S ‘-Subsites
Pauly et al. Specificity determinants of human cathepsin S revealed by crystal structures of complexes
Shieh et al. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2)
Chowdhury et al. Exploring inhibitor binding at the S′ subsites of cathepsin L
Lingott et al. High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: insight into inhibitor binding
Maes et al. Structure of chymopapain at 1.7 Å resolution
Peters et al. Pro region C-terminus: protease active site interactions are critical in catalyzing the folding of α-lytic protease
Wlodawer et al. Inhibitor complexes of the Pseudomonas serine-carboxyl proteinase
Berggård et al. Fragment complementation studies of protein stabilization by hydrophobic core residues
Riley et al. KLK4 inhibition by cyclic and acyclic peptides: structural and dynamical insights into standard-mechanism protease inhibitors
Vulpetti et al. Structure-based library design and fragment screening for the identification of reversible complement factor D protease inhibitors
Jílková et al. Druggable hot spots in the schistosomiasis cathepsin B1 target identified by functional and binding mode analysis of potent vinyl sulfone inhibitors
Sarkar et al. Inhibiting matrix metalloproteinase-2 activation by perturbing protein–protein interactions using a cyclic peptide
Luo et al. Crystallographic analysis of bacterial signal peptidase in ternary complex with arylomycin A2 and a β-sultam inhibitor
Gombos et al. Probing conformational plasticity of the activation domain of trypsin: the role of glycine hinges
Radisky et al. Binding, proteolytic, and crystallographic analyses of mutations at the protease− inhibitor interface of the subtilisin BPN ‘/chymotrypsin inhibitor 2 complex
Li et al. Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core
Reiling et al. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases